In partnership with iPierian, Gladstone is using a novel technique to develop drug treatments for human disease. The method is based on a technique for reprogramming adult cells to become induced pluripotent stem cells, which are very similar to embryonic stem cells. Gladstone scientist Bruce Conklin is using the iPS cells to effectively perform "drug trials in a dish."
Link to this comment:
All Comments (0)